Evidence map›Paper›PMID 40592952›Full record

ArticleScientific reports2025

MEN: leveraging explainable multimodal encoding network for precision prediction of CYP450 inhibitors.

Abena Achiaa Atwereboannah, Wei-Ping Wu, Mugahed A Al-Antari, Sophyani B Yussif, Chukwuebuka J Ejiyi, Edwin K Tenagyei, Grace-Mercure B Kissanga, Gyarteng S A Emmanuel, Yeong Hyeon Gu, Emmanuel Ahene

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abena Achiaa AtwereboannahSchool of Computer Science and Engineering, University of Electronic Science and Technology, Chengdu, People's Republic of China.
Wei-Ping WuSchool of Computer Science and Engineering, University of Electronic Science and Technology, Chengdu, People's Republic of China. wei-ping.wu@uestc.edu.cn.
Mugahed A Al-AntariDepartment of Artificial Intelligence and Data Science, College of AI Convergence, Daeyang AI Center, Sejong University, Seoul, 05006, Korea. en.mualshz@sejong.ac.kr.
Sophyani B YussifSchool of Computer Science and Engineering, University of Electronic Science and Technology, Chengdu, People's Republic of China.
Chukwuebuka J EjiyiDepartment of Nuclear Technology Engineering, Chengdu University of Technology, Chengdu, People's Republic of China.
Edwin K TenagyeiSchool of Engineering and Built Environment, Griffith University, Brisbane, QLD, 4111, Australia.
Grace-Mercure B KissangaSchool of Life Science and Technology and Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu, 610054, People's Republic of China.
Gyarteng S A EmmanuelSchool of Information and Communication Engineering, University of Electronic Science and Technology, Chengdu, People's Republic of China.
Yeong Hyeon GuDepartment of Artificial Intelligence and Data Science, College of AI Convergence, Daeyang AI Center, Sejong University, Seoul, 05006, Korea. yhgu@sejong.ac.kr.
Emmanuel AheneDepartment of Computer Science, Kwame Nkrumah University of Science and Technology Kumasi, Kumasi, Ghana.

Funding

This work was supported by the IITP(Institute of Information & Communications Technology Planning & Evaluation)-ITRC(Information Technology Research Center) grant funded by the Korea government(Ministry of Science and ICT) (IITP-2025-RS-2024-00437191)This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) RS-2023-00256517
6 · The paper itself

Abstract

Drug-drug interactions (DDIs) present serious risks in clinical settings, especially for patients who are prescribed multiple medications. A major factor contributing to these interactions is the inhibition of cytochrome P450 (CYP450) enzymes, which are vital for drug metabolism. As a result, reliably identifying compounds that may inhibit CYP450 enzymes is a key step in drug development. However, existing machine learning (ML) methods often fall short in terms of prediction accuracy and biological interpretability. To address this challenge, we introduce a Multimodal Encoder Network (MEN) aimed at improving the prediction of CYP450 inhibitors. This model combines three types of molecular data (chemical fingerprints, molecular graphs, and protein sequences) by applying specialized encoders tailored to each format. Specifically, the Fingerprint Encoder Network (FEN) processes molecular fingerprints, the Graph Encoder Network (GEN) extracts structural features from graph-based representations, and the Protein Encoder Network (PEN) captures sequential patterns from protein sequences. By integrating these diverse data types, MEN can extract complementary information that enhances predictive performance. The encoded outputs from FEN, GEN, and PEN are fused to build a comprehensive feature representation. An explainable AI (XAI) module is incorporated into the model to support biological interpretation, using visualization techniques such as heatmaps. The model was trained and validated using two datasets: chemical structures in SMILES format from PubChem and protein sequences of five CYP450 isoforms (1A2, 2C9, 2C19, 2D6, and 3A4) obtained from the Protein Data Bank (PDB). MEN achieved an average accuracy of 93.7% across all isoforms. The individual encoders performed with accuracies of 80.8% (FEN), 82.3% (GEN), and 81.5% (PEN). Additional performance results include an AUC of 98.5%, sensitivity of 95.9%, specificity of 97.2%, precision of 80.6%, F1-score of 83.4%, and a Matthews correlation coefficient (MCC) of 88.2%. All data and code are available at https://github.com/GracedAbena/MEN-Leveraging-Explainable-Multimodal-Encoding-Network .

Indexed as

Cytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemDrug InteractionsHumansMachine LearningCytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemAttentive hierarchical graph isomorphism network (AHGIN)Cytochrome P450InhibitorInterpretable artificial intelligence (IAI)Residual multi local attention (ReMLA)Self-attention

Identifiers

PMID40592952
PMCPMC12214809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.